2025 MIDD Webinar Series | Model Platform to Predict Long-Term Clinical Outcome for Patients with Relapsed and Refractory Multiple Myeloma

Mayu Osawa has over a decade of experience in the pharmaceutical industry at Bristol Myers Squibb, where she serves as a Director in Pharmacometrics. She has extensive experience in both early and late development programs, leading modeling work across therapeutic areas including oncology, immunology, and hematology to support drug development decisions, dose selection, and health authority submissions. She obtained her Ph.D. in biostatistics from Kitasato University.

Dr Géraldine Cellière is a multidisciplinary scientist with a background in statistics and modeling. She holds an engineering degree from Ecole Polytechnique (Paris, France) and a Master in computational biology from ETH Zürich (Switzerland). After an experience as assistant project manager at SoBios, she did a PhD in systems biology and multi-scale modeling at INRIA Paris and received her doctoral degree in 2016. Géraldine then joined Lixoft (now part of Simulations Plus) as VP Application. There, she leads the team in charge of all pre- and post-sales activities (demonstrations, trainings, technical support), research activities (improvement and development of new methods, application to case studies, publications), as well as the MonolixSuite development (product specification and testing).